| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;91:2204-2213.)
© 1995 American Heart Association, Inc.
Articles |
Limitations and Late Complications of Third-Generation Automatic Cardioverter-Defibrillators
From the Cardiac Arrhythmia Service and the Cardiac Surgery Service, Harvard Medical School and the Massachusetts General Hospital, Boston.
Correspondence to Jeremy Ruskin, MD, Massachusetts General Hospital, Fruit St, Boston, MA 02114.
Background This study examines the limitations and complex management problems associated with the use of tiered-therapy, implantable cardioverter-defibrillators (ICDs).
Methods and Results The study group comprises the first 154 patients undergoing implantation of tiered-therapy ICDs at our institution. Pulse generators from three different manufacturers were used. In 39 patients, a complete nonthoracotomy lead system was used. The perioperative mortality was 1.3%. Of these 154 patients, 37% experienced late postoperative problems. Twenty-one patients required system revision within 36.5 months (mean, 8.57±11.3) of surgery. Reasons for revision were spurious shocks due to electrode fractures (3) or electrode adapter malfunction (2), inadequate signal from endocardial rate-sensing electrodes (3), superior vena cava or right ventricular coil migration (5), failure to correct tachyarrhythmias due to a postimplant rise in defibrillation threshold (5), or pulse generator failure (3). One of these patients required system removal for infection after revision of an endocardial lead. A further 32 patients received inappropriate shocks for atrial fibrillation with a rapid ventricular response or sinus tachycardia. Two of these patients also received shocks for ventricular tachycardia initiated by antitachycardia pacing triggered by atrial fibrillation. Ventricular pacing for bradycardia was associated with inappropriate shocks due to excessive autogain in 2 patients.
Conclusions Despite the major diagnostic and therapeutic advantages of tiered-therapy ICDs, a significant proportion of patients continue to experience hardware-related complications or receive inappropriate shocks.
Key Words: pacing • defibrillators • arrhythmia • defibrillation
This article has been cited by other articles:
 |
|
 |
|
  N. Sadoul, R. Mletzko, F. Anselme, R. Bowes, W. Schols, C. Kouakam, G. Casteigneau, R. Luise, N. Iscolo, E. Aliot, et al. Incidence and Clinical Relevance of Slow Ventricular Tachycardia in Implantable Cardioverter-Defibrillator Recipients: An International Multicenter Prospective Study Circulation, August 16, 2005; 112(7): 946 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Senges-Becker, M. Klostermann, R. Becker, A. Bauer, K. E. Siegler, H. A. Katus, and W. Schoels What is the "Optimal" follow-up schedule for ICD patients? Europace, January 1, 2005; 7(4): 319 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A.M.J. Theuns, A. P. J. Klootwijk, D. M. Goedhart, and L. J.L.M. Jordaens Prevention of inappropriate therapy in implantable cardioverter-defibrillators: Results of a prospective, randomized study of tachyarrhythmia detection algorithms J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2362 - 2367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Becker, J. Ruf-Richter, J. C. Senges-Becker, A. Bauer, S. Weretka, F. Voss, H. A. Katus, and W. Schoels Patient alert in implantable cardioverter defibrillators: toy or tool? J. Am. Coll. Cardiol., July 7, 2004; 44(1): 95 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C A Rinaldi, R D Simon, A Baszko, J Bostock, D Elliot, C A Bucknall, and J S S Gill A 17 year experience of inappropriate shock therapy in patients with implantable cardioverter-defibrillators: are we getting any better? Heart, March 1, 2004; 90(3): 330 - 331. [Full Text] [PDF]
|
|
|
|
|
|
C. Kouakam, S. Kacet, J.-R. Hazard, A. Ferraci, H. Mansour, P. Defaye, J.-M. Davy, M. Lambiez, and on behalf of the Ventak AV Investigators Performance of a dual-chamber implantable defibrillator algorithm for discrimination of ventricular from supraventricular tachycardia Europace, January 1, 2004; 6(1): 32 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Quesada, J.ús Almendral, F. Arribas, R. Ricci, C. Wolpert, P. Adragao, E. Cobo, X. Navarro, and on behalf DATAS investigators The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator Europace, January 1, 2004; 6(2): 142 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. L. E. Bracke, A. Meijer, and L. M. van Gelder Malfunction of endocardial defibrillator leads and lead extraction: where do they meet? Europace, January 1, 2002; 4(1): 19 - 24. [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Sanders, M. A. Hlatky, N. R. Every, K. M. McDonald, P. A. Heidenreich, L. S. Parsons, and D. K. Owens Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction Ann Intern Med, November 20, 2001; 135(10): 870 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Gronefeld and S. H Hohnloser What do implantable cardioverter/defibrillators teach us about the mechanisms of sudden cardiac death? Cardiovasc Res, May 1, 2001; 50(2): 232 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Gollob and J. J. Seger Current Status of the Implantable Cardioverter-Defibrillator Chest, April 1, 2001; 119(4): 1210 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nisam A Prophylactic ICD? Who are the patients? What is the device? Europace, January 1, 2001; 3(4): 269 - 274. [PDF]
|
|
|
|
 |
|
 T. Korte, W. Jung, G. Ostermann, C. Wolpert, S. Spehl, B. Esmailzadeh, and B. Luderitz Hospital readmission after transvenous cardioverter/defibrillator implantation. A single centre study Eur. Heart J., July 2, 2000; 21(14): 1186 - 1191. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Oto, A. Yildirir, G. Kabakci, and E. Atalar Inappropriate Shocks Diagnosed by Stored Electrograms of Implantable Cardioverter Defibrillators: Two Case Reports Angiology, May 1, 2000; 51(5): 425 - 430. [Abstract] [PDF]
|
|
|
|
|
|
M. Greene, D. Newman, M. Geist, M. Paquette, D. Heng, and P. Dorian Is electrical storm in ICD patients the sign of a dying heart?: Outcome of patients with clusters of ventricular tachyarrhythmias Europace, January 1, 2000; 2(3): 263 - 269. [Abstract] [PDF]
|
|
|
|
|
|
L. A. Pires, M. H. Lehmann, R. T. Steinman, J. J. Baga, C. D. Schuger, and Participating Investigators Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses J. Am. Coll. Cardiol., January 1, 1999; 33(1): 24 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gradaus, B. Lamp, D. Hammel, M. Loick, H.H. Scheld, G. Breithardt, and M. Block Multiple hardware complications in a patient with an ICD Europace, January 1, 1999; 1(4): 270 - 274. [Abstract] [PDF]
|
|
|
|
|
|
D Babuty, L Fauchier, and P Cosnay Inappropriate shocks delivered by implantable cardiac defibrillators during oversensing of activity of diaphagmatic muscle Heart, January 1, 1999; 81(1): 94 - 96. [Abstract] [Full Text]
|
|
|
|
|
|
R. Ruppel, C. A. Schluter, S. Boczor, T. Meinertz, M. Schluter, K.-H. Kuck, and R. Cappato Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators J. Am. Coll. Cardiol., November 15, 1998; 32(6): 1724 - 1730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rosenqvist, T. Beyer, M. Block, K. den Dulk, J. Minten, and F. Lindemans Adverse Events With Transvenous Implantable Cardioverter-Defibrillators : A Prospective Multicenter Study Circulation, August 18, 1998; 98(7): 663 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. E. Marchlinski Predicting Arrhythmic Death : A Plea for Standardized Reporting Techniques and Data Based on Continuous Electrocardiographic Monitoring Circulation, September 16, 1997; 96(6): 1713 - 1716. [Full Text]
|
|
|
|
 |
|
 P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron The Management of Hypertrophic Cardiomyopathy N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785. [Full Text] [PDF]
|
|
|
|
|
|
M. Nair, N. Saoudi, D. Kroiss, and B. Letac Automatic Arrhythmia Identification Using Analysis of the Atrioventricular Association: Application to a New Generation of Implantable Defibrillators Circulation, February 18, 1997; 95(4): 967 - 973. [Abstract] [Full Text]
|
|
|
|
|
|
G. J. Fahy, E. B. Sgarbossa, P. J. Tchou, and S. L. Pinski Hospital Readmission in Patients Treated With Tiered-Therapy Implantable Defibrillators Circulation, September 15, 1996; 94(6): 1350 - 1356. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Ferguson Jr, C. Ferguson, K Crites, and P Crimmins-Reda THE ADDITIONAL HOSPITAL COSTS GENERATED IN THE MANAGEMENT OF COMPLICATIONS OF PACEMAKER AND DEFIBRILLATOR IMPLANTATIONS J. Thorac. Cardiovasc. Surg., April 1, 1996; 111(4): 742 - 752. [Abstract] [Full Text]
|
|
|
|
 |
|
 IMPLANTABLE DEFIBRILLATORS: PROMISE AND PROBLEMS Journal Watch (General), April 21, 1995; 1995(421): 2 - 2. [Full Text]
|
|